 | • レポートコード：MRC23Q35788 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の抗ストレプトリジン試薬試験市場について調査・分析し、世界の抗ストレプトリジン試薬試験市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（定性的、半定量的、定量的）、用途別セグメント分析（病院、研究所、診断研究所、学術・研究機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Erba Mannheim、Lab Care Diagnostics (India) Pvt. Ltd.、Adaltis S.r.l.、Lorne Laboratories Limited、DiaSys Diagnostic Systems GmbH、Diagnostic Automation/Cortez Diagnostics, Inc.、Biosystems S.A.、Abnova Corporation、Randox Laboratories Limited、Kamiya Biomedical Companyなどが含まれています。 世界の抗ストレプトリジン試薬試験市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、抗ストレプトリジン試薬試験市場規模を推定する際に考慮しました。本レポートは、抗ストレプトリジン試薬試験の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、抗ストレプトリジン試薬試験に関するビジネス上の意思決定に役立てることを目的としています。 ・抗ストレプトリジン試薬試験市場の概要 - 抗ストレプトリジン試薬試験のタイプ別セグメント - 世界の抗ストレプトリジン試薬試験市場規模：タイプ別分析（定性的、半定量的、定量的） - 抗ストレプトリジン試薬試験の用途別セグメント - 世界の抗ストレプトリジン試薬試験市場規模：用途別分析（病院、研究所、診断研究所、学術・研究機関、その他） - 世界の抗ストレプトリジン試薬試験市場規模予測（2018年-2029年） ・抗ストレプトリジン試薬試験市場の成長トレンド - 抗ストレプトリジン試薬試験の地域別市場規模（2018年-2029年） - 抗ストレプトリジン試薬試験市場ダイナミクス - 抗ストレプトリジン試薬試験の業界動向 - 抗ストレプトリジン試薬試験市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：定性的、半定量的、定量的 - 世界の抗ストレプトリジン試薬試験のタイプ別市場規模（2018年-2023年） - 世界の抗ストレプトリジン試薬試験のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、研究所、診断研究所、学術・研究機関、その他 - 世界の抗ストレプトリジン試薬試験の用途別市場規模（2018年-2023年） - 世界の抗ストレプトリジン試薬試験の用途別市場規模（2024年-2029年） ・抗ストレプトリジン試薬試験の地域別市場規模 - 北米の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - アメリカの抗ストレプトリジン試薬試験市場規模（2018年-2029年） - ヨーロッパの抗ストレプトリジン試薬試験市場規模（2018年-2029年） - アジア太平洋の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - 中国の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - 日本の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - 韓国の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - インドの抗ストレプトリジン試薬試験市場規模（2018年-2029年） - オーストラリアの抗ストレプトリジン試薬試験市場規模（2018年-2029年） - 中南米の抗ストレプトリジン試薬試験市場規模（2018年-2029年） - 中東・アフリカの抗ストレプトリジン試薬試験市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Erba Mannheim、Lab Care Diagnostics (India) Pvt. Ltd.、Adaltis S.r.l.、Lorne Laboratories Limited、DiaSys Diagnostic Systems GmbH、Diagnostic Automation/Cortez Diagnostics, Inc.、Biosystems S.A.、Abnova Corporation、Randox Laboratories Limited、Kamiya Biomedical Company ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Anti-Streptolysin Reagents Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anti-Streptolysin Reagents Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-Streptolysin Reagents Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Anti-Streptolysin Reagents Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anti-Streptolysin Reagents Test include Erba Mannheim, Lab Care Diagnostics (India) Pvt. Ltd., Adaltis S.r.l., Lorne Laboratories Limited, DiaSys Diagnostic Systems GmbH, Diagnostic Automation/Cortez Diagnostics, Inc., Biosystems S.A., Abnova Corporation and Randox Laboratories Limited, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Streptolysin Reagents Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Streptolysin Reagents Test.
The Anti-Streptolysin Reagents Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-Streptolysin Reagents Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Streptolysin Reagents Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Erba Mannheim
Lab Care Diagnostics (India) Pvt. Ltd.
Adaltis S.r.l.
Lorne Laboratories Limited
DiaSys Diagnostic Systems GmbH
Diagnostic Automation/Cortez Diagnostics, Inc.
Biosystems S.A.
Abnova Corporation
Randox Laboratories Limited
Kamiya Biomedical Company
Segment by Type
Qualitative
Semi-Quantitative
Quantitative
Segment by Application
Hospitals
Research Laboratories
Diagnostic Laboratories
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Streptolysin Reagents Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Streptolysin Reagents Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Qualitative
1.2.3 Semi-Quantitative
1.2.4 Quantitative
1.3 Market by Application
1.3.1 Global Anti-Streptolysin Reagents Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Diagnostic Laboratories
1.3.5 Academic & Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Streptolysin Reagents Test Market Perspective (2018-2029)
2.2 Anti-Streptolysin Reagents Test Growth Trends by Region
2.2.1 Global Anti-Streptolysin Reagents Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-Streptolysin Reagents Test Historic Market Size by Region (2018-2023)
2.2.3 Anti-Streptolysin Reagents Test Forecasted Market Size by Region (2024-2029)
2.3 Anti-Streptolysin Reagents Test Market Dynamics
2.3.1 Anti-Streptolysin Reagents Test Industry Trends
2.3.2 Anti-Streptolysin Reagents Test Market Drivers
2.3.3 Anti-Streptolysin Reagents Test Market Challenges
2.3.4 Anti-Streptolysin Reagents Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Streptolysin Reagents Test Players by Revenue
3.1.1 Global Top Anti-Streptolysin Reagents Test Players by Revenue (2018-2023)
3.1.2 Global Anti-Streptolysin Reagents Test Revenue Market Share by Players (2018-2023)
3.2 Global Anti-Streptolysin Reagents Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Streptolysin Reagents Test Revenue
3.4 Global Anti-Streptolysin Reagents Test Market Concentration Ratio
3.4.1 Global Anti-Streptolysin Reagents Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Streptolysin Reagents Test Revenue in 2022
3.5 Anti-Streptolysin Reagents Test Key Players Head office and Area Served
3.6 Key Players Anti-Streptolysin Reagents Test Product Solution and Service
3.7 Date of Enter into Anti-Streptolysin Reagents Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Streptolysin Reagents Test Breakdown Data by Type
4.1 Global Anti-Streptolysin Reagents Test Historic Market Size by Type (2018-2023)
4.2 Global Anti-Streptolysin Reagents Test Forecasted Market Size by Type (2024-2029)
5 Anti-Streptolysin Reagents Test Breakdown Data by Application
5.1 Global Anti-Streptolysin Reagents Test Historic Market Size by Application (2018-2023)
5.2 Global Anti-Streptolysin Reagents Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti-Streptolysin Reagents Test Market Size (2018-2029)
6.2 North America Anti-Streptolysin Reagents Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anti-Streptolysin Reagents Test Market Size by Country (2018-2023)
6.4 North America Anti-Streptolysin Reagents Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Streptolysin Reagents Test Market Size (2018-2029)
7.2 Europe Anti-Streptolysin Reagents Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anti-Streptolysin Reagents Test Market Size by Country (2018-2023)
7.4 Europe Anti-Streptolysin Reagents Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Streptolysin Reagents Test Market Size (2018-2029)
8.2 Asia-Pacific Anti-Streptolysin Reagents Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anti-Streptolysin Reagents Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Anti-Streptolysin Reagents Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Streptolysin Reagents Test Market Size (2018-2029)
9.2 Latin America Anti-Streptolysin Reagents Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anti-Streptolysin Reagents Test Market Size by Country (2018-2023)
9.4 Latin America Anti-Streptolysin Reagents Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Streptolysin Reagents Test Market Size (2018-2029)
10.2 Middle East & Africa Anti-Streptolysin Reagents Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anti-Streptolysin Reagents Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Anti-Streptolysin Reagents Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Erba Mannheim
11.1.1 Erba Mannheim Company Detail
11.1.2 Erba Mannheim Business Overview
11.1.3 Erba Mannheim Anti-Streptolysin Reagents Test Introduction
11.1.4 Erba Mannheim Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.1.5 Erba Mannheim Recent Development
11.2 Lab Care Diagnostics (India) Pvt. Ltd.
11.2.1 Lab Care Diagnostics (India) Pvt. Ltd. Company Detail
11.2.2 Lab Care Diagnostics (India) Pvt. Ltd. Business Overview
11.2.3 Lab Care Diagnostics (India) Pvt. Ltd. Anti-Streptolysin Reagents Test Introduction
11.2.4 Lab Care Diagnostics (India) Pvt. Ltd. Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.2.5 Lab Care Diagnostics (India) Pvt. Ltd. Recent Development
11.3 Adaltis S.r.l.
11.3.1 Adaltis S.r.l. Company Detail
11.3.2 Adaltis S.r.l. Business Overview
11.3.3 Adaltis S.r.l. Anti-Streptolysin Reagents Test Introduction
11.3.4 Adaltis S.r.l. Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.3.5 Adaltis S.r.l. Recent Development
11.4 Lorne Laboratories Limited
11.4.1 Lorne Laboratories Limited Company Detail
11.4.2 Lorne Laboratories Limited Business Overview
11.4.3 Lorne Laboratories Limited Anti-Streptolysin Reagents Test Introduction
11.4.4 Lorne Laboratories Limited Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.4.5 Lorne Laboratories Limited Recent Development
11.5 DiaSys Diagnostic Systems GmbH
11.5.1 DiaSys Diagnostic Systems GmbH Company Detail
11.5.2 DiaSys Diagnostic Systems GmbH Business Overview
11.5.3 DiaSys Diagnostic Systems GmbH Anti-Streptolysin Reagents Test Introduction
11.5.4 DiaSys Diagnostic Systems GmbH Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.5.5 DiaSys Diagnostic Systems GmbH Recent Development
11.6 Diagnostic Automation/Cortez Diagnostics, Inc.
11.6.1 Diagnostic Automation/Cortez Diagnostics, Inc. Company Detail
11.6.2 Diagnostic Automation/Cortez Diagnostics, Inc. Business Overview
11.6.3 Diagnostic Automation/Cortez Diagnostics, Inc. Anti-Streptolysin Reagents Test Introduction
11.6.4 Diagnostic Automation/Cortez Diagnostics, Inc. Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.6.5 Diagnostic Automation/Cortez Diagnostics, Inc. Recent Development
11.7 Biosystems S.A.
11.7.1 Biosystems S.A. Company Detail
11.7.2 Biosystems S.A. Business Overview
11.7.3 Biosystems S.A. Anti-Streptolysin Reagents Test Introduction
11.7.4 Biosystems S.A. Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.7.5 Biosystems S.A. Recent Development
11.8 Abnova Corporation
11.8.1 Abnova Corporation Company Detail
11.8.2 Abnova Corporation Business Overview
11.8.3 Abnova Corporation Anti-Streptolysin Reagents Test Introduction
11.8.4 Abnova Corporation Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.8.5 Abnova Corporation Recent Development
11.9 Randox Laboratories Limited
11.9.1 Randox Laboratories Limited Company Detail
11.9.2 Randox Laboratories Limited Business Overview
11.9.3 Randox Laboratories Limited Anti-Streptolysin Reagents Test Introduction
11.9.4 Randox Laboratories Limited Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.9.5 Randox Laboratories Limited Recent Development
11.10 Kamiya Biomedical Company
11.10.1 Kamiya Biomedical Company Company Detail
11.10.2 Kamiya Biomedical Company Business Overview
11.10.3 Kamiya Biomedical Company Anti-Streptolysin Reagents Test Introduction
11.10.4 Kamiya Biomedical Company Revenue in Anti-Streptolysin Reagents Test Business (2018-2023)
11.10.5 Kamiya Biomedical Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details